UW Medicine dedicates $180M to planned EHR overhaul

The University of Washington (UW) School of Medicine will begin a complete overhaul of its electronic health record (EHR) system—and it’s not going to be cheap. The school’s finance committee approved $180 million to replace existing Cerner and Epic systems with a single integrated platform.

“UW Medicine clinicians document clinical care across a mosaic of systems,” according to university’s project plan. Specifically, there are numerous medical record systems which clinicians and support teams must access every time care is provided to a patient. The Clinical Transformation Project (CT) will reduce the number of systems and create workflows and efficiencies that will simplify and standardize work across the care continuum for years to come.

The project, which will put UW’s eight facilities onto a single EHR system, is scheduled to take 30 months. Of the total cost, $159.5 million will be allocated to direct project costs and another $20.8 million will address site-specific costs, including staff training. The university estimates project costs will be primarily labor (67 percent), along with software and vendor services (both 12 percent).

“Moving to a single outpatient/inpatient EHR will not only mitigate the risk related to the end of the Soarian contract at NWH, it will allow for UW Medicine to sunset more than 70 other ancillary systems that are currently in use across the enterprise,” according to university documents. “IT estimates significant savings in the licensing and subscription costs, and in the cost incurred to support the proliferation of systems across UW Medicine.”

""
Nicholas Leider, Managing Editor

Nicholas joined TriMed in 2016 as the managing editor of the Chicago office. After receiving his master’s from Roosevelt University, he worked in various writing/editing roles for magazines ranging in topic from billiards to metallurgy. Currently on Chicago’s north side, Nicholas keeps busy by running, reading and talking to his two cats.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.